Thrombolysis will continue to be the mainstay for acute stroke treatment

Thrombolysis will continue to be the mainstay for acute stroke treatment

Thrombolysis will continue to be the mainstay for acute stroke treatment, despite the recent revolution in neurointerventional clot retrieval. However, as there are ongoing limitations of thrombolysis of bleeding risk and reduced efficacy in large clots – what possible therapeutic advancements can complement or act as an adjuvant to thrombolysis? Neurointervention – effective, but limited […]

Read More

January 2nd, 2017

Steadying confidence for clinical trials in India

For over 30 years, India has been conducting global clinical trials. With over 500 sites and over a billion people, India was a key destination for clinical trials for its vast treatment naïve clinical population. However, the environment has fluctuated throughout recent years, as The Central Drugs Standard Control Organization (CDSCO), India’s regulatory agency for […]

Read More

December 21st, 2016

Not-for-profit Organizations make a difference in fighting global epidemics

Developing nations suffer acutely from health epidemics due to lack of resources to adequately combat these epidemics. Many of these epidemics are managed reasonable well in developed nations but with low socioeconomic levels and poor living conditions, coupled with weak health infrastructure, diseases such as enteric and diarrheal diseases and AIDS are still major killers […]

Read More

November 29th, 2016

India improves processes for clinical trials

New initiatives from the country’s regulator aim to smooth the registration of trials and ensure prospective participants fully understand what will be involved through mandatory AV recording of the consent process. Clinical trial applications in India are taking a step forward, with the approval of a Central Drugs Standard Control Organisation (CDSCO) IT-enabled system from […]

Read More

November 17th, 2016
New circulars released by CDSCO

Streamlined clinical trial requirements in India now in place

Effective 2nd August 2016, the Central Drugs Standard Control Organization (CDSCO) India released new circulars in relation to the conduct of clinical trials. These new circulars have modified the trial requirements for sponsors wishing to conduct clinical trials in India. Furthermore, the CDSCO have addressed matters that may assist in reducing clinical trial timelines and […]

Read More

November 9th, 2016
Clinical trials for Rotavirus are critical in emerging countries

Clinical Trials for Rotavirus are Critical in Emerging Countries

On a global scale, rotavirus causes over 500,000 deaths in children per year, particularly in emerging countries. Rotavirus is a contagious virus that can cause inflammation of the stomach and intestines – also identified as gastroenteritis. India has predicted that almost every child would experience an episode of rotavirus gastroenteritis by the age of 5. […]

Read More

October 22nd, 2016

Streamlined clinical trial requirements in India now in place

Effective 2nd August 2016, the Central Drugs Standard Control Organization (CDSCO) India released new circulars in relation to the conduct of clinical trials. These new circulars have modified the trial requirements for sponsors wishing to conduct clinical trials in India. Furthermore, the CDSCO have addressed matters that may assist in reducing clinical trial timelines and […]

Read More

August 12th, 2016

New Horizons in India

The Central Drugs Standard Control Organization (CDSCO), India’s regulatory agency for clinical research, has made a series of announcements and corrections

Read More

July 22nd, 2014

George Clinical expands in the Asian region

In order to meet the growing needs of our customers, George Clinical has expanded its geographical footprint within Asia. In 2012 we saw the opening of a second George Clinical office in India in Bengaluru to complement our head office in Hyderabad. With many of our large outcomes studies recruiting patients in India there is […]

Read More

April 16th, 2013

required
required
required
required
I wish to subscribe to George Clinical communications.
required

Add George Clinical to your network